$MBBC
Marathon Bancorp, Inc. /MD/

2022 Q3 Form 10-K Financial Statement

#000155837022014665 Filed on September 28, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022
Revenue $2.027M $7.157M
YoY Change 6.49% 10.38%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $76.63K $208.0K
YoY Change 51.56% 0.29%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $314.3K $947.8K
YoY Change 34.07% -13.15%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $627.8K $1.772M
YoY Change 14.03% -4.25%
Income Tax $116.7K $437.4K
% Of Pretax Income 18.58% 24.68%
Net Earnings $511.2K $1.335M
YoY Change 22.55% -2.79%
Net Earnings / Revenue 25.22% 18.65%
Basic Earnings Per Share $0.24 $0.62
Diluted Earnings Per Share $0.24 $0.62
COMMON SHARES
Basic Shares Outstanding 2.270M 2.229M 2.145M
Diluted Shares Outstanding 2.148M 2.145M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $17.90M $8.428M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $2.360M $1.676M $1.676M
YoY Change 30.48% -9.4% -9.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $578.6K
YoY Change 114.53%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $235.8M $220.0M $220.5M
YoY Change 14.12% 2.99% 3.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $1.176M
YoY Change -18.92%
Total Long-Term Liabilities $1.176M
YoY Change -90.06%
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities $1.176M
Total Liabilities $204.6M $189.3M $189.3M
YoY Change 16.04% 2.99% 2.99%
SHAREHOLDERS EQUITY
Retained Earnings $23.93M $23.42M
YoY Change 6.35% 6.04%
Common Stock $8.545M $8.510M
YoY Change 0.44% 0.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $31.17M $30.74M $31.22M
YoY Change
Total Liabilities & Shareholders Equity $235.8M $220.0M $220.5M
YoY Change 14.12% 2.99% 3.22%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022
OPERATING ACTIVITIES
Net Income $511.2K $1.335M
YoY Change 22.55% -2.79%
Depreciation, Depletion And Amortization $76.63K $208.0K
YoY Change 51.56% 0.29%
Cash From Operating Activities $1.476M $825.5K
YoY Change 227.02% -43.5%
INVESTING ACTIVITIES
Capital Expenditures $61.67K $34.09K
YoY Change 567.51% -61.46%
Acquisitions
YoY Change
Other Investing Activities -$44.18M
YoY Change 113.04%
Cash From Investing Activities -$5.656M -$44.22M
YoY Change -23.73% 108.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.65M 5.772M
YoY Change -278.34% -86.11%
NET CHANGE
Cash From Operating Activities 1.476M 825.5K
Cash From Investing Activities -5.656M -44.22M
Cash From Financing Activities 13.65M 5.772M
Net Change In Cash 9.473M -37.62M
YoY Change -164.79% -272.78%
FREE CASH FLOW
Cash From Operating Activities $1.476M $825.5K
Capital Expenditures $61.67K $34.09K
Free Cash Flow $1.415M $791.4K
YoY Change 219.91% -42.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2145095
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2142474
CY2022 dei Security Exchange Name
SecurityExchangeName
NONE
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001835385
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Other Comprehensive Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfOtherComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
CY2022Q1 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Other Comprehensive Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfOtherComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
CY2022Q2 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Other Comprehensive Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfOtherComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2229497
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2269700
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
698837
CY2022Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentNet
CY2022Q3 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-56269
CY2022 dei Entity Registrant Name
EntityRegistrantName
MARATHON BANCORP, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2191258
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
500 Scott Street
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Wausau
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
WI
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
54403
CY2022 dei City Area Code
CityAreaCode
715
CY2022 dei Local Phone Number
LocalPhoneNumber
845-7331
CY2022 dei Security12b Title
Security12bTitle
None
CY2022 dei Trading Symbol
TradingSymbol
None
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Public Float
EntityPublicFloat
15250144
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2269700
CY2022 dei Auditor Firm
AuditorFirmId
1884
CY2022 dei Auditor Name
AuditorName
Bonadio & Co., LLP
CY2022 dei Auditor Location
AuditorLocation
Syracuse, New York
CY2022Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
2418041
CY2021Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
1989643
CY2022Q2 us-gaap Federal Funds Sold
FederalFundsSold
6010000
CY2021Q2 us-gaap Federal Funds Sold
FederalFundsSold
44059000
CY2022Q2 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
8428041
CY2021Q2 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
46048643
CY2022Q2 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
1945073
CY2021Q2 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
2062463
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10617238
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10909764
CY2022Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
419000
CY2021Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
770438
CY2022Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
532363
CY2021Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
708949
CY2022Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2195050
CY2021Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2186182
CY2022Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
185629872
CY2021Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
144169318
CY2022Q2 us-gaap Interest Receivable
InterestReceivable
565929
CY2021Q2 us-gaap Interest Receivable
InterestReceivable
552516
CY2022Q2 us-gaap Investment Owned Restricted Cost
InvestmentOwnedRestrictedCost
323000
CY2021Q2 us-gaap Investment Owned Restricted Cost
InvestmentOwnedRestrictedCost
262200
CY2022Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
9193315
CY2021Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
5968734
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1676060
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1849917
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
96820
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
269715
CY2022Q2 us-gaap Other Assets
OtherAssets
1010869
CY2021Q2 us-gaap Other Assets
OtherAssets
825081
CY2022Q2 us-gaap Assets
Assets
220018580
CY2021Q2 us-gaap Assets
Assets
213627300
CY2022Q2 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
23698115
CY2021Q2 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
23633008
CY2022Q2 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
164402333
CY2021Q2 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
148323109
CY2021Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
10372148
CY2022Q2 us-gaap Other Liabilities
OtherLiabilities
1175565
CY2021Q2 us-gaap Other Liabilities
OtherLiabilities
1449884
CY2022Q2 us-gaap Liabilities
Liabilities
189276013
CY2021Q2 us-gaap Liabilities
Liabilities
183778149
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2269700
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2229497
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
22295
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
22295
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
8487400
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
8484019
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
23423432
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
22088669
CY2022Q2 us-gaap Unearned Esop Shares
UnearnedESOPShares
821531
CY2021Q2 us-gaap Unearned Esop Shares
UnearnedESOPShares
866499
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-369029
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
120667
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
30742567
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
29849151
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
220018580
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
213627300
CY2022 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
6758834
CY2021 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
6090126
CY2022 us-gaap Interest Income Debt Securities Available For Sale Operating
InterestIncomeDebtSecuritiesAvailableForSaleOperating
331106
CY2021 us-gaap Interest Income Debt Securities Available For Sale Operating
InterestIncomeDebtSecuritiesAvailableForSaleOperating
361565
CY2022 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
67202
CY2021 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
32463
CY2022 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
7157142
CY2021 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
6484154
CY2022 us-gaap Interest Expense Deposits
InterestExpenseDeposits
940953
CY2021 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1049621
CY2022 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
6814
CY2021 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
41606
CY2022 us-gaap Interest Expense
InterestExpense
947767
CY2021 us-gaap Interest Expense
InterestExpense
1091227
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6209375
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5392927
CY2022 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
6209375
CY2021 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
5392927
CY2022 mara Service Charges On Deposit Accounts
ServiceChargesOnDepositAccounts
165495
CY2021 mara Service Charges On Deposit Accounts
ServiceChargesOnDepositAccounts
168016
CY2022 mara Mortgage Banking Income
MortgageBankingIncome
689334
CY2021 mara Mortgage Banking Income
MortgageBankingIncome
1527087
CY2022 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
224580
CY2021 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
164667
CY2022 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
14000
CY2021 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
10840
CY2022 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
24938
CY2021 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
25051
CY2022 us-gaap Noninterest Income
NoninterestIncome
1118347
CY2021 us-gaap Noninterest Income
NoninterestIncome
1895661
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3135242
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3345057
CY2022 us-gaap Occupancy Net
OccupancyNet
710842
CY2021 us-gaap Occupancy Net
OccupancyNet
670954
CY2022 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
393768
CY2021 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
463131
CY2022 us-gaap Professional Fees
ProfessionalFees
656954
CY2021 us-gaap Professional Fees
ProfessionalFees
366526
CY2022 us-gaap Marketing Expense
MarketingExpense
77626
CY2021 us-gaap Marketing Expense
MarketingExpense
62586
CY2022 mara Debit Card Expenses
DebitCardExpenses
78142
CY2021 mara Debit Card Expenses
DebitCardExpenses
89347
CY2022 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
67900
CY2021 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
78400
CY2022 us-gaap Other Noninterest Expense
OtherNoninterestExpense
435103
CY2021 us-gaap Other Noninterest Expense
OtherNoninterestExpense
361808
CY2022 us-gaap Noninterest Expense
NoninterestExpense
5555577
CY2021 us-gaap Noninterest Expense
NoninterestExpense
5437809
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1772145
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1850779
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
437382
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
477720
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1334763
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1373059
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2145095
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2142474
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1334763
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1373059
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-682767
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-100981
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-186050
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-26851
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-496717
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-74130
CY2022 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
14000
CY2022 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
3815
CY2022 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
10185
CY2022 us-gaap Oci Debt Securities Available For Sale Transfer To Held To Maturity Adjustment From Aoci For Amortization Of Gain Loss After Tax
OciDebtSecuritiesAvailableForSaleTransferToHeldToMaturityAdjustmentFromAociForAmortizationOfGainLossAfterTax
-17206
CY2021 us-gaap Oci Debt Securities Available For Sale Transfer To Held To Maturity Adjustment From Aoci For Amortization Of Gain Loss After Tax
OciDebtSecuritiesAvailableForSaleTransferToHeldToMaturityAdjustmentFromAociForAmortizationOfGainLossAfterTax
-128072
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-489696
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
53942
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
845067
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1427001
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
20782335
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1400000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8505977
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1373059
CY2021 mara Purchase Of Employee Stock Ownership Plan Shares
PurchaseOfEmployeeStockOwnershipPlanShares
87397
CY2021 mara Purchase Of Employee Stock Ownership Plan Shares Value
PurchaseOfEmployeeStockOwnershipPlanSharesValue
873970
CY2021 mara Employee Stock Ownership Plan Esop Amount Of Committed To Be Released Shares In Shares
EmployeeStockOwnershipPlanEsopAmountOfCommittedToBeReleasedSharesInShares
747
CY2021 mara Employee Stock Ownership Plan Esop Amount Of Committed To Be Released Shares
EmployeeStockOwnershipPlanEsopAmountOfCommittedToBeReleasedShares
7808
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
53942
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
29849151
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1334763
CY2022 mara Employee Stock Ownership Plan Esop Amount Of Committed To Be Released Shares In Shares
EmployeeStockOwnershipPlanEsopAmountOfCommittedToBeReleasedSharesInShares
4497
CY2022 mara Employee Stock Ownership Plan Esop Amount Of Committed To Be Released Shares
EmployeeStockOwnershipPlanEsopAmountOfCommittedToBeReleasedShares
48349
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-489696
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
30742567
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1334763
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1373059
CY2022 us-gaap Depreciation
Depreciation
207951
CY2021 us-gaap Depreciation
Depreciation
207351
CY2022 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
535665
CY2021 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
429082
CY2022 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
48349
CY2021 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
7808
CY2022 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-119555
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-132600
CY2022 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
308444
CY2021 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
1046851
CY2022 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
14000
CY2021 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
10840
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
362678
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
458420
CY2022 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
224580
CY2021 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
164667
CY2022 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
13413
CY2021 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
52776
CY2022 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
16779892
CY2021 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
50642912
CY2022 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
17088336
CY2021 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
51689763
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
185787
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
461726
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-274319
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-28213
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
825532
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1031934
CY2022 mara Net Change Interest Bearing Deposits In Other Financial Institutions
NetChangeInterestBearingDepositsInOtherFinancialInstitutions
-117390
CY2021 mara Net Change Interest Bearing Deposits In Other Financial Institutions
NetChangeInterestBearingDepositsInOtherFinancialInstitutions
117913
CY2022 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
3500000
CY2021 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1112500
CY2022 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
2987332
CY2021 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
4979796
CY2022 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
196744
CY2021 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
2257018
CY2022 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
3000000
CY2022 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
60800
CY2022 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
40924889
CY2021 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
26821343
CY2021 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
74920
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34094
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88471
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44218317
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20828493
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
8505977
CY2021 mara Payments To Acquire Employee Stock Ownership Plan Esop Shares
PaymentsToAcquireEmployeeStockOwnershipPlanEsopShares
873970
CY2022 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
16144331
CY2021 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
37941198
CY2021 us-gaap Payments For Federal Home Loan Bank Advances
PaymentsForFederalHomeLoanBankAdvances
8000000
CY2022 mara Borrowings Repayments Of Ppplf Funding Net
BorrowingsRepaymentsOfPpplfFundingNet
-10372148
CY2021 mara Borrowings Repayments Of Ppplf Funding Net
BorrowingsRepaymentsOfPpplfFundingNet
3997250
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5772183
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
41570455
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-37620602
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
21773896
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46048643
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24274747
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8428041
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46048643
CY2022 us-gaap Interest Paid Net
InterestPaidNet
944133
CY2021 us-gaap Interest Paid Net
InterestPaidNet
1073861
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
79000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10000
CY2021Q2 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
1226223
CY2021Q2 us-gaap Sale Of Stock Percentage Of Ownership Before Transaction
SaleOfStockPercentageOfOwnershipBeforeTransaction
0.550
CY2021Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1003274
CY2021Q2 us-gaap Share Price
SharePrice
10.00
CY2021Q2 us-gaap Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
0.450
CY2021Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
10000000.0
CY2021Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1400000
CY2021Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
8500000
CY2022 mara Number Of Business Facilities
NumberOfBusinessFacilities
4
CY2022Q2 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
0
CY2021Q2 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
0
CY2021Q2 us-gaap Foreclosed Assets
ForeclosedAssets
0
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant changes in the near term relate to the determination of the allowance for loan losses, valuation of deferred tax assets, other-than-temporary impairment of debt securities and fair value of financial assets and liabilities.</span></p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentrations of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The majority of the Company’s loans and commitments to extend credit have been granted to customers in the Company’s market area. Although the Company’s loan portfolio is diversified, a substantial portion of the Company’s customers’ ability to honor their contracts is dependent upon the local business economy in which the Company operates. The concentration of credit by type of loan is set forth in Note 4.</p>
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
CY2022Q2 us-gaap Investment Owned Restricted Cost
InvestmentOwnedRestrictedCost
323000
CY2021Q2 us-gaap Investment Owned Restricted Cost
InvestmentOwnedRestrictedCost
262200
CY2022Q2 us-gaap Foreclosed Assets
ForeclosedAssets
0
CY2020Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
1699977
CY2022Q2 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
78000
CY2021Q2 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
131000
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
489293
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10617238
CY2022Q2 us-gaap Fair Value Disclosure Offbalance Sheet Risks Face Amount Asset
FairValueDisclosureOffbalanceSheetRisksFaceAmountAsset
85493000
CY2021Q2 us-gaap Fair Value Disclosure Offbalance Sheet Risks Face Amount Asset
FairValueDisclosureOffbalanceSheetRisksFaceAmountAsset
80628000
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022 us-gaap Advertising Expense
AdvertisingExpense
77626
CY2021 us-gaap Advertising Expense
AdvertisingExpense
62586
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
250438
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
45572
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
1512281
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
58
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
6
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
4
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1334763
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1373059
CY2022 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
2229497
CY2021 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
2229497
CY2022 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
84402
CY2021 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
87023
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2145095
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2142474
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Reclassifications</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Certain reclassifications of amounts previously reported have been made to the accompanying consolidated financial statements to maintain consistency between periods presented. The reclassification had no impact on net income or equity.</p>
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
5
CY2021 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
486205
CY2021Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2186182
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
2186182
CY2021Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2186182
CY2021Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
539423
CY2021Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
146334172
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
698837
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10617238
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10909764
CY2022Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
532363
CY2021Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
708949
CY2022Q2 us-gaap Debt Securities Available For Sale And Held To Maturity
DebtSecuritiesAvailableForSaleAndHeldToMaturity
11149601
CY2021Q2 us-gaap Debt Securities Available For Sale And Held To Maturity
DebtSecuritiesAvailableForSaleAndHeldToMaturity
11618713
CY2022Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
11053947
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
52584
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
10649706
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
305630
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
45572
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10909764
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
407241
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
8901446
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
82052
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
1179360
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
489293
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
10080806
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
33460
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1261843
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
12112
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
170000
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
168670
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
4478401
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
4329548
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
3580000
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
3379966
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
8228401
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
7878184
CY2022Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
11053947
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10617238
CY2022Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
532363
CY2022Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
419000
CY2022Q2 us-gaap Debt Securities Available For Sale Restricted
DebtSecuritiesAvailableForSaleRestricted
667000
CY2021Q2 us-gaap Debt Securities Available For Sale Restricted
DebtSecuritiesAvailableForSaleRestricted
1118000
CY2021 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2022 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2022 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
14000
CY2022Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
187900474
CY2021Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
146873595
CY2022Q2 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
75552
CY2021Q2 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
518095
CY2022Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2195050
CY2021Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2186182
CY2022Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
185629872
CY2021Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
144169318
CY2021Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2186182
CY2022 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
8868
CY2022Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2195050
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
2195050
CY2022Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2195050
CY2022Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
193385
CY2022Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
187707089
CY2022Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
187900474
CY2021Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
146873595
CY2022Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
63785
CY2021Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
178394
CY2022Q2 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
193385
CY2022Q2 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
193385
CY2022 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
199080
CY2022 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
13428
CY2021Q2 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
539423
CY2021Q2 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
597069
CY2021 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
563291
CY2021 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
35391
CY2020 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2021 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2022Q2 mara Financing Receivables Commitments To Lend Additional Funds On Restructured Loans
FinancingReceivablesCommitmentsToLendAdditionalFundsOnRestructuredLoans
0
CY2022 mara Loans And Leases Receivable Deferred Income Recognized
LoansAndLeasesReceivableDeferredIncomeRecognized
483484
CY2021 mara Loans And Leases Receivable Deferred Income Recognized
LoansAndLeasesReceivableDeferredIncomeRecognized
404038
CY2022 mara Financing Receivables Threshold Loan Modification Period Due To Covid19
FinancingReceivablesThresholdLoanModificationPeriodDueToCovid19
P3M
CY2022 mara Financing Receivables Loan Modification Potential Extension Period Maximum
FinancingReceivablesLoanModificationPotentialExtensionPeriodMaximum
P6M
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4546477
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4547050
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2870417
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2697133
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1676060
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1849917
CY2022 us-gaap Depreciation
Depreciation
207951
CY2021 us-gaap Depreciation
Depreciation
207351
CY2022Q2 mara Operating Lease Number Of Branch Locations Leased
OperatingLeaseNumberOfBranchLocationsLeased
2
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
100126
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
76248
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
58056
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
60422
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
56375
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
351227
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
97172
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
100564
CY2022Q2 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
19400000
CY2022Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
9193315
CY2021Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
5968734
CY2022Q2 us-gaap Time Deposit Maturities Year One
TimeDepositMaturitiesYearOne
25868955
CY2022Q2 us-gaap Time Deposit Maturities Year Two
TimeDepositMaturitiesYearTwo
10859433
CY2022Q2 us-gaap Time Deposit Maturities Year Three
TimeDepositMaturitiesYearThree
7075523
CY2022Q2 us-gaap Time Deposit Maturities Year Four
TimeDepositMaturitiesYearFour
4899477
CY2022Q2 us-gaap Time Deposit Maturities Year Five
TimeDepositMaturitiesYearFive
9225126
CY2022Q2 us-gaap Time Deposit Maturities After Year Five
TimeDepositMaturitiesAfterYearFive
2074436
CY2022Q2 us-gaap Time Deposits
TimeDeposits
60002950
CY2022Q2 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
24266673
CY2022Q2 mara Brokered Deposits
BrokeredDeposits
19840000
CY2021Q2 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
22287654
CY2021Q2 mara Brokered Deposits
BrokeredDeposits
17682000
CY2021Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
0
CY2022Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
0
CY2022Q2 us-gaap Financial Instruments Owned And Pledged As Collateral Amount Eligible To Be Repledged By Counterparty
FinancialInstrumentsOwnedAndPledgedAsCollateralAmountEligibleToBeRepledgedByCounterparty
37536518
CY2021Q2 us-gaap Financial Instruments Owned And Pledged As Collateral Amount Eligible To Be Repledged By Counterparty
FinancialInstrumentsOwnedAndPledgedAsCollateralAmountEligibleToBeRepledgedByCounterparty
35421507
CY2022Q2 us-gaap Pledged Financial Instruments Not Separately Reported Securities For Federal Home Loan Bank
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForFederalHomeLoanBank
323000
CY2021Q2 us-gaap Pledged Financial Instruments Not Separately Reported Securities For Federal Home Loan Bank
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForFederalHomeLoanBank
262200
CY2022Q2 mara Federal Home Loan Bank Advances Repricing Daily
FederalHomeLoanBankAdvancesRepricingDaily
5000000.0
CY2022Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
0
CY2021Q2 us-gaap Federal Home Loan Bank Advances Activity For Year Maximum Outstanding At Any Month End
FederalHomeLoanBankAdvancesActivityForYearMaximumOutstandingAtAnyMonthEnd
8000000
CY2021 us-gaap Federal Home Loan Bank Advances Activity For Year Average Interest Rate For Year
FederalHomeLoanBankAdvancesActivityForYearAverageInterestRateForYear
0.0029
CY2021Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
0
CY2022Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
0
CY2022Q2 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
556082
CY2021Q2 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
514353
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
236800
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
432127
CY2022Q2 mara Deferred Tax Asset Debt Securities Available For Sale
DeferredTaxAssetDebtSecuritiesAvailableForSale
119187
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
131723
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
38814
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
29699
CY2022Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
7038
CY2021Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
13304
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
401839
CY2021Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
606853
CY2022Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
67202
CY2021Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
80471
CY2022Q2 mara Deferred Tax Liabilities Allowance For Loan Losses
DeferredTaxLiabilitiesAllowanceForLoanLosses
21882
CY2021Q2 mara Deferred Tax Liabilities Allowance For Loan Losses
DeferredTaxLiabilitiesAllowanceForLoanLosses
21882
CY2022Q2 us-gaap Deferred Tax Liabilities Mortgage Servicing Rights
DeferredTaxLiabilitiesMortgageServicingRights
215327
CY2021Q2 us-gaap Deferred Tax Liabilities Mortgage Servicing Rights
DeferredTaxLiabilitiesMortgageServicingRights
163942
CY2021Q2 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
70596
CY2022Q2 mara Deferred Tax Liabilities Deferred Loan Expenses
DeferredTaxLiabilitiesDeferredLoanExpenses
352
CY2022Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
256
CY2021Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
247
CY2022Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
305019
CY2021Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
337138
CY2022Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
96820
CY2021Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
269715
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
74704
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
19300
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
362678
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
458420
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
437382
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
477720
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
372150
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
388665
CY2022 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
8579
CY2021 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
13936
CY2022 mara Effective Income Tax Rate Reconciliation Earnings On Bank Owned Life Insurance Amount
EffectiveIncomeTaxRateReconciliationEarningsOnBankOwnedLifeInsuranceAmount
47162
CY2021 mara Effective Income Tax Rate Reconciliation Earnings On Bank Owned Life Insurance Amount
EffectiveIncomeTaxRateReconciliationEarningsOnBankOwnedLifeInsuranceAmount
34580
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
107169
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
106736
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
13804
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
30835
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
437382
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
477720
CY2022 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
3815
CY2022Q2 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
27152000
CY2022Q2 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.1217
CY2022 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.15
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
65516
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
75000
CY2022 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
873970
CY2022 mara Purchase Of Employee Stock Ownership Plan Shares
PurchaseOfEmployeeStockOwnershipPlanShares
87397
CY2022 us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
10.00
CY2022Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.055
CY2022 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
48349
CY2022Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
4497
CY2021 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
7808
CY2021Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
747
CY2022Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Committed To Be Released Shares
EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares
82153
CY2022Q2 mara Employee Stock Ownership Plan Esop Value Of Shares Committed To Be Released
EmployeeStockOwnershipPlanEsopValueOfSharesCommittedToBeReleased
893825
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P3Y
CY2022Q2 mara Significant Unobservable Input Float
SignificantUnobservableInputFloat
0.01
CY2022 mara Employee Medical Benefit Plan Maximum Claims Per Employee
EmployeeMedicalBenefitPlanMaximumClaimsPerEmployee
30000
CY2022 mara Employee Medical Benefit Plan Aggregate Stop Loss
EmployeeMedicalBenefitPlanAggregateStopLoss
1000000
CY2022 us-gaap Health Care Organization Health Care Costs Gross
HealthCareOrganizationHealthCareCostsGross
447827
CY2021 us-gaap Health Care Organization Health Care Costs Gross
HealthCareOrganizationHealthCareCostsGross
568947
CY2022Q2 mara Employee Medical Benefit Plan Liability
EmployeeMedicalBenefitPlanLiability
41954
CY2021Q2 mara Employee Medical Benefit Plan Liability
EmployeeMedicalBenefitPlanLiability
118481
CY2022 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
14000
CY2022Q2 us-gaap Tier One Leverage Capital Required For Capital Adequacy
TierOneLeverageCapitalRequiredForCapitalAdequacy
17848000
CY2022Q2 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
0.080
CY2022Q2 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
20080000
CY2022Q2 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.090
CY2021Q2 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
25452000
CY2021Q2 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.1247
CY2021Q2 us-gaap Tier One Leverage Capital Required For Capital Adequacy
TierOneLeverageCapitalRequiredForCapitalAdequacy
15313000
CY2021Q2 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
0.075
CY2021Q2 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
17355000
CY2021Q2 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.085
CY2022Q2 mara Net Worth Of Entity
NetWorthOfEntity
26783484
CY2022Q2 mara General Loan Loss Reserve
GeneralLoanLossReserve
2195050
CY2022Q2 mara Net Worth Of Entity Percent Of Total Assets
NetWorthOfEntityPercentOfTotalAssets
0.1317
CY2021Q2 mara Net Worth Of Entity
NetWorthOfEntity
25842077
CY2021Q2 mara General Loan Loss Reserve
GeneralLoanLossReserve
2186182
CY2021Q2 mara Net Worth Of Entity Percent Of Total Assets
NetWorthOfEntityPercentOfTotalAssets
0.1312
CY2022Q2 mara Commitments To Grant Loans Percentage Outstanding With Fixed Interest Rate
CommitmentsToGrantLoansPercentageOutstandingWithFixedInterestRate
0.81
CY2022Q2 mara Commitments To Grant Loans Percentage Outstanding With Variable Interest Rate
CommitmentsToGrantLoansPercentageOutstandingWithVariableInterestRate
0.19
CY2021Q2 mara Commitments To Grant Loans Percentage Outstanding With Fixed Interest Rate
CommitmentsToGrantLoansPercentageOutstandingWithFixedInterestRate
0.72
CY2021Q2 mara Commitments To Grant Loans Percentage Outstanding With Variable Interest Rate
CommitmentsToGrantLoansPercentageOutstandingWithVariableInterestRate
0.28
CY2022 mara Significant Unobservable Input
SignificantUnobservableInput
The Level 3 valuation is based on the 5/30 swap curve
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
2000000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
0
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
2000000
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
-100000
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
1900000
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
0
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
1900000

Files In Submission

Name View Source Status
0001558370-22-014665-index-headers.html Edgar Link pending
0001558370-22-014665-index.html Edgar Link pending
0001558370-22-014665.txt Edgar Link pending
0001558370-22-014665-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mara-20220630.xsd Edgar Link pending
mara-20220630x10k.htm Edgar Link pending
mara-20220630xex21.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mara-20220630x10k_htm.xml Edgar Link completed
mara-20220630xex23.htm Edgar Link pending
mara-20220630xex31d1.htm Edgar Link pending
mara-20220630xex31d2.htm Edgar Link pending
mara-20220630xex32d1.htm Edgar Link pending
mara-20220630xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
mara-20220630_def.xml Edgar Link unprocessable
mara-20220630_pre.xml Edgar Link unprocessable
mara-20220630_lab.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mara-20220630_cal.xml Edgar Link unprocessable